Effect of lycopene on doxorubicin-induced cardiotoxicity: An echocardiographic, histological and morphometrical assessment

Carregando...
Imagem de Miniatura

Data

2007-07-01

Autores

Ferreira, Ana Lúcia dos Anjos [UNESP]
Russell, Robert Mitchell
Rocha, Noeme Sousa [UNESP]
Placido Ladeira, Marcelo Sady
Salvadori, Daisy Maria Favero [UNESP]
Munhoz Oliveira Nascimento, Maria Carolina
Matsui, Mirna
Carvalho, Flavio Augusto
Tang, Guangwen
Matsubara, Luiz Shiguero [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Blackwell Publishing

Resumo

Doxorubicin is an excellent chemotherapeutic agent utilized for several types of cancer but the irreversible doxorubicin-induced cardiac damage is the major limitation for its use. Oxidative stress seems to be associated with some phase of the toxicity mechanism process. To determine if lycopene protects against doxorubicin-induced cardiotoxicity, male Wistar rats were randomly assigned either to control, lycopene, doxorubicin or doxorubicin + lycopene groups. They received corn oil (control, doxorubicin) or lycopene (5 mg/kg body weight a day) (lycopene, doxorubicin + lycopene) by gavage for a 7-week period. They also received saline (control, lycopene) or doxorubicin (4 mg/kg) (doxorubicin, doxorubin + lycopene) intraperitoneally by week 3, 4 5 and 6. Animals underwent echocardiogram and were killed for tissue analyses by week 7. Mean lycopene levels (nmol/kg) in liver were higher in the doxorubicin + lycopene group (5822.59) than in the lycopene group (2496.73), but no differences in lycopene were found in heart or Plasma of these two groups. Lycopene did not prevent left ventricular systolic dysfunction induced by doxorubicin. However, morphologic examination revealed that doxorubicin-induced myocyte damage was significantly suppressed in rats treated with lycopene. Doxorubicin treatment was followed by increase of myocardium interstitial collagen volume fraction. Our results show that: (i) doxorubicin-induced cardiotoxicity was confirmed by echocardiogram and morphological evaluations; (ii) lycopene absorption was confirmed by its levels in heart, liver and plasma; (iii) lycopene supplementation provided myocyte protection without preventing interstitial collagen accumulation increase; (iv) doxorubicin-induced cardiac dysfunction was not prevented by lycopene supplementation; and (v) lycopene depletion was not observed in plasma and tissues from animals treated with doxorubicin.

Descrição

Palavras-chave

Como citar

Basic & Clinical Pharmacology & Toxicology. Oxford: Blackwell Publishing, v. 101, n. 1, p. 16-24, 2007.